Expression of α-tubulin and γ-tubulin in premalignant lesion and carcinoma of breast and the significance thereof

National Medical Journal of China

Volumn 86, Issue 1, 2006, Pages 56-60

  Niu, Yun ^a   Wang, Ying ^a   Yu, Yong ^a   Ding, Xiu Min ^a   Lü, Shu Hua ^a   Xiao, Xu Qi ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast carcinoma; Centrosome; Premalignant lesion; Tubulin

Indexed keywords

ALPHA TUBULIN; GAMMA TUBULIN; KI 67 ANTIGEN; MESSENGER RNA;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PHENOTYPE; PRECANCER; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CENTROSOME; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PRECANCEROUS CONDITIONS; RNA, MESSENGER; SURVIVAL ANALYSIS; TUBULIN;

EID: 31144467715     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Fukasawa K. Introduction. Centrosome. Oncogene, 2002, 21:6140-6145.
2. Bornens M. Centrosome compsition and microtubule anchoring mechanisms. Curr Opin Cell Biol, 2002,14: 25-34.
3. Katayama H, Brinkley WR, Sen S. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev, 2003, 22: 451-464.
4. D'Assoro AB, Barrett SL, Folk C, et al. Amplified centrosomes in breast cancer: a potential indicator of tumor aggressiveness. Breast Cancer Res Treat, 2002, 75:25-34.
5. Kawamura K, Moriyama M, Shiba N, et al. Centrosome hyperamplification and chromosomal instability in bladder cancer. Eur Urol, 2003,43:505-515.
6. Tavassoli FA, Devilee P, eds. The WHO classification of tumors of the breast and female genital organs. Lyon: IARC Press, 2003. 10-112.
7. Tanaka K, Iwamoto S, Gon G, et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res, 2000, 6:127-134.
8. Schneeweiss A, Sinn HP, Ehemann V, et al. Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression. Int J Cancer, 2003, 107:346-352.
9. Page DL, Jensen RA, Simpson JF, et al. Historical and epidemiologic background of human premalignant breast disease. J Mammary Gland Biol Neoplasia,2000, 5:341-349.
10. Chinese source. 1999, 26:2-5.
11. Nigg EA. Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Can, 2002, 2:815-825.
12. Lingle WL, Barrett SL, Negron VC, et al. Centrosome amplification drives chromosomal instability in breast tumor development. Proc Natl Acad Sci U S A,2002, 99:1978-1983.
13. Marx J. Do centrosome abnormalities lead to cancer? Science Cell Biology, 2001, 292:426-429.
14. Goepfert TM, Adigun YE, Zhong L, et al. Centrosome amplification and overexpression of aurora are early events in rat mammary carcinogenesis. Cancer Res, 2002,62:4115-4122.